Kamada Ltd. (KMDA) vs Alpha Teknova, Inc. (TKNO)

Kamada Ltd. and Alpha Teknova, Inc. are both Drug Manufacturers Specialty & Generic companies. Kamada Ltd. is the larger, with a market value of $451.7M against $408.0M — 1.1× the size. Alpha Teknova, Inc. has negative trailing earnings, so its P/E is not meaningful; Kamada Ltd. trades at 20.4×. Kamada Ltd. grew revenue faster over the last twelve months: 13.2% against 12.3%. Kamada Ltd. has the higher net margin (11.6% vs −38.4%) and the higher return on invested capital (8.47% vs −16.9%). Across the 19 metrics below, Kamada Ltd. leads on 17 and Alpha Teknova, Inc. on 2.

Valuation

Metric KMDA TKNO Drug Manufacturers Specialty & Generic median
P/E 20.45 n/m 19.25
P/S 2.34 8.69 2.11
P/B 1.67 6.07 1.78
Price to free cash flow 17.09 n/m 16.14
EV/EBITDA 9.19 n/m 12.58
EV/Sales 2.07 8.69 2.73
Earnings yield 4.89% (4.38%) (4.38%)
Free cash flow yield 5.85% (1.94%) 0.00%

Profitability

Metric KMDA TKNO Drug Manufacturers Specialty & Generic median
Gross margin 40.82% 34.60% 53.94%
Operating margin 14.51% (36.19%) 0.00%
Net margin 11.60% (38.37%) 0.00%
Free cash flow margin 13.72% (16.83%) 0.00%
Return on equity 8.40% (24.19%) (0.40%)
Return on assets 5.92% (16.25%) (3.32%)
Return on invested capital 8.47% (16.93%) 0.00%

Growth

Metric KMDA TKNO Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 13.17% 12.27% 10.01%
EPS growth (last fiscal year) 40.00% 43.86% 49.06%
Revenue growth, 5-year CAGR 6.25% 5.30% 6.74%
Net income growth, 5-year CAGR 3.34% 0.00% 0.00%

Health

Metric KMDA TKNO Drug Manufacturers Specialty & Generic median
Debt to equity 0.02 0.21 0.05
Current ratio 4.06 4.49 2.31
Net debt to EBITDA (1.59) 0.75 0.97

Dividend

Metric KMDA TKNO Drug Manufacturers Specialty & Generic median
Dividend yield 5.41% — 1.57%
Payout ratio 1.11 — 0.27

Size

Metric KMDA TKNO Drug Manufacturers Specialty & Generic median
Market cap 451.71m 408.03m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack